1. Thrombosis, Cancer, and NOACs

3. Program Goals

4. Cancer-Associated VTE

5. Oral Anticoagulants Are Preferred

6. Patient Persistence With Anticoagulation: LMWH vs Oral Agents

7. Hokusai VTE-Cancer Study: Design

8. Hokusai VTE-Cancer Study: Outcomes

9. Hokusai VTE-Cancer Study: Results

10. Hokusai VTE-Cancer Study: Results (cont)

11. Hokusai VTE-Cancer Study: Results (cont)

12. SELECT-D Trial: Design

13. SELECT-D Trial: Primary Endpoint

14. SELECT-D Trial: Results

15. Can Oral Anticoagulation Replace LMWH?

16. Patient Adherence

17. GI Bleeding

18. Patient Preferences

19. Treatment vs Prophylaxis

20. CASSINI Trial: Design

21. AVERT Trial: Design

22. Summary

23. Abbreviations